TABLE 1.
Dosing Interval | Definition of Adherence, d | No. (%) of Subjects |
||
---|---|---|---|---|
Nonadherent, Early | Adherent | Nonadherent, Late | ||
Doses 1–2a | 24–84 | 0 (0.0) | 939 (40) | 1427 (60) |
Doses 2–3b | 80–152 | 25 (1.8) | 651 (46) | 741 (52) |
Doses 1–3b | 164–213 | 33 (2.3) | 438 (31) | 949 (67) |
Among female patients who received at least 2 doses (N = 2366).
Among female patients who received 3 doses (N = 1477).